Human pregnancy and generation of anti-angiotensin receptor and anti-perlecan antibodies

Transplant International

Volumn 27, Issue 5, 2014, Pages 467-474

  Hönger, Gideon ^a   Cardinal, Heloise ^b   Dieudé, Mélanie ^b   Buser, Andreas ^a   Hösli, Irene ^a   Dragun, Duska ^c   Hébert, Marie Josée ^b   Schaub, Stefan ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

anti angiotensin receptor antibodies; anti perlecan antibodies; antibody mediated rejection; non HLA antibodies; pregnancy

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTIBODY; HLA ANTIBODY; PERLECAN; PERLECAN ANTIBODY; UNCLASSIFIED DRUG; ALLOANTIBODY; AUTOANTIBODY; HLA ANTIGEN; PEPTIDE FRAGMENT; PROTEOHEPARAN SULFATE;

ADULT; AGED; ANTIBODY MEDIATED REJECTION; ARTICLE; CONTROLLED STUDY; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENDER; HUMAN; LIVE BIRTH; MALE; NORMAL HUMAN; PREDICTOR VARIABLE; PREGNANCY; PRIORITY JOURNAL; SENSITIZATION; SPONTANEOUS ABORTION; BIOSYNTHESIS; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AUTOANTIBODIES; FEMALE; HEPARAN SULFATE PROTEOGLYCANS; HLA ANTIGENS; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PREGNANCY; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 84898821819     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12282     Document Type: Article

References (22)

1. Sumitran-Karuppan S, Tyden G, Reinholt F, Berg U, Moller E,. Hyperacute rejections of two consecutive renal allografts and early loss of the third transplant caused by non-HLA antibodies specific for endothelial cells. Transpl Immunol 1997; 5: 321.
2. Amico P, Honger G, Bielmann D, et al,. Incidence and prediction of early antibody-mediated rejection due to non-human leukocyte antigen-antibodies. Transplantation 2008; 85: 1557.
3. Dragun D, Muller DN, Brasen JH, et al,. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection. N Engl J Med 2005; 352: 558.
4. Reinsmoen NL, Lai CH, Heidecke H, et al,. Anti-angiotensin type 1 receptor antibodies associated with antibody mediated rejection in donor HLA antibody negative patients. Transplantation 2010; 90: 1473.
5. Cardinal H, Dieude M, Brassard N, et al,. Antiperlecan antibodies are novel accelerators of immune-mediated vascular injury. Am J Transplant 2013; 13: 861.
6. Sis B, Mengel M, Haas M, et al,. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
7. Mengel M, Sis B, Haas M, et al,. Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant 2012; 12: 563.
8. Scornik JC, Guerra G, Schold JD, Srinivas TR, Dragun D, Meier-Kriesche HU,. Value of posttransplant antibody tests in the evaluation of patients with renal graft dysfunction. Am J Transplant 2007; 7: 1808.
9. Oro C, Qian H, Thomas WG,. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther 2007; 113: 210.
10. Arsenault J, Lehoux J, Lanthier L, et al,. A single-nucleotide polymorphism of alanine to threonine at position 163 of the human angiotensin II type 1 receptor impairs Losartan affinity. Pharmacogenet Genomics 2010; 20: 377.
11. Iozzo RV,. Basement membrane proteoglycans: from cellar to ceiling. Nat Rev Mol Cell Biol 2005; 6: 646.
12. Honger G, Fornaro I, Granado C, Tiercy JM, Hosli I, Schaub S,. Frequency and determinants of pregnancy-induced child-specific sensitization. Am J Transplant 2013; 13: 746.
13. Giral M, Foucher Y, Dufay A, et al,. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss. Am J Transplant 2013; 13: 2567.
14. Ostensen M, Villiger PM, Forger F,. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev 2012; 11: A437.
15. Betz AG,. Immunology: tolerating pregnancy. Nature 2012; 490: 47.
16. Herse F, Verlohren S, Wenzel K, et al,. Prevalence of agonistic autoantibodies against the angiotensin II type 1 receptor and soluble fms-like tyrosine kinase 1 in a gestational age-matched case study. Hypertension 2009; 53: 393.
17. Pallet N, Dieude M, Cailhier J, Hebert M,. The molecular legacy of apoptosis in transplantation. Am J Transplant 2012; 12: 1378.
18. Taniguchi M, Rebellato LM, Cai J, et al,. Higher risk of kidney graft failure in the presence of anti-angiotensin II type-1 receptor antibodies. Am J Transplant 2013; 13: 2577.
19. Riemekasten G, Philippe A, Nather M, et al,. Involvement of functional autoantibodies against vascular receptors in systemic sclerosis. Ann Rheum Dis 2011; 70: 530.
20. Tinckam K, Campbell P,. Angiotensin II type 1 receptor antibodies: great expectations? Am J Transplant 2013; 13: 2515.
21. van Rood JJ, Eernisse JG, van Leeuwen A,. Leucocyte antibodies in sera from pregnant women. Nature 1958; 181: 1735.
22. Thorsby E,. A short history of HLA. Tissue Antigens 2009; 74: 101.